Extracellular matrix stiffness regulates the activation of urethral fibroblasts via FAK/ROCK-1/YAP pathway
陈烨辉,陈佳茵,朱君明,陈航,柯志滨,林菲,薛学义,魏勇,郑清水,许宁
DOI: https://doi.org/10.3760/cma.j.cn421213-20210706-01198
2022-01-01
Abstract:Objective:To investigate the effects and mechanism of extracellular matrix stiffness on the activation of urethral fibroblasts (UFBs).Methods:UFBs extracted from urethral scar tissues derived from patients who underwent surgery in Department of Urology, the First Affiliated Hospital of Fujian Medical, between June 2020 and February 2021, were seeded on the prepared matrigels of different matrix stiffness, which were made using polydimethylsiloxane with hardener (60∶1 for soft group, 40∶1 for moderate group, and 30∶1 for stiff group), and cultured for follow-up experiments. Morphologic characteristics of UFBs cultured on matrigels of different matrix stiffness were observed. Western blotting was performed to detect the expression levels of α-smooth muscle actin (α-SMA), collagen Ⅰ and collagen Ⅲ. The expression levels of FAK/ROCK-1/YAP pathway markers, and the effects of integrin inhibitor Cilengtide (20 ng/ml) on the pathway were also examined, to investigate whether extracellular matrix stiffness regulated the activation of UFBs via this signaling pathway. ANOVA and Student
t test were used for statistical analysis.
Results:The shape of UFBs changed from elliptic to fusiform and the pseudopodias of UFBs became more and longer, with the matrix stiffness of matrigel increasing. The relative expression levels of α-SMA, collagen Ⅰand collagen Ⅲ in the soft, moderate and stiff groups were 0.140±0.004, 0.815±0.030 and 1.385±0.051 (
F=989.247,
P<0.05), (0.138±0.004, 0.947±0.021 and 1.263±0.028 (
F=2 415.159,
P<0.05), and 0.138±0.004, 0.947±0.021 and 1.263±0.028 (
F=1 661.310,
P<0.05), respectively, which indicated that the expression levels of α-SMA, collagen Ⅰand collagen Ⅲ were elevated along with the increase of extracellular matrix stiffness. When compared with the soft group, the expression levels of p-FAK (1.282±0.029 vs. 0.430±0.009,
t=48.262,
P<0.05), ROCK-1 (1.366±0.111 vs. 0.474±0.034,
t=13.300,
P<0.05) and YAP (1.272±0.020 vs. 0.908±0.007,
t=30.254,
P<0.05) in the stiff group were increased, while the expression level of p-YAP (0.589±0.006 vs. 1.028±0.008,
t=-74.860,
P<0.05) decreased. However, alterations of p-FAK, ROCK-1, YAP and p-YAP expression levels caused by the elevation of extracellular matrix stiffness were attenuated when adding the integrin inhibitor Cilengtide.
Conclusion:Extracellular matrix stiffness regulates the activation of UFBs through FAK/ROCK-1/YAP pathway medicated by integrin.